SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
July 5, 2006
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
|(Commission File Number)|| |
13200 Progress Boulevard
Alachua, Florida 32615
(Address of principal executive offices including zip code)
Registrants telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 3.02 UNREGISTERED SALES OF EQUITY SECURITIES.
On July 5, 2006, Oragenics, Inc. (the Company) announced that 1,046,606 warrants to purchase common stock previously issued by the Company were exercised by four warrant holders, including Company Director George Hawes, resulting in aggregate proceeds to the Company of $600,000. As previously reported by the Company on Form 8-K, the private placement offering and sale of the warrants was made in reliance upon the exemption from registration provided by Section 4(2) of the Securities Act of 1933.
A copy of the July 5, 2006 press release announcing the exercise of the warrants is attached to this report as Exhibit 99.1 and is incorporated herein by reference.
Item 8.01 OTHER EVENTS.
On July 5, 2006, the Company issued a press release announcing the exercise of warrants, its financial position as a result of the receipt of aggregate proceeds of $600,000 in connection with the exercise and its current burn rate. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 FINANCIAL INFORMATION AND EXHIBITS
|99.1||Press Release dated July 5, 2006|
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|July 6, 2006|| |
Robert T. Zahradnik
President and Chief Executive Officer